OctoPlus' Executive Committee is responsible for the day-to-day management of our operations under the supervision of the Supervisory Board. The Executive Committee consists of Jan Egberts (CEO), Susan Swarte (CFO) and Gerben Moolhuizen (CBO).
Jan Egberts - Chief Executive Officer
Jan Hendrik Egberts, M.D. brings over 20 years of experience in the pharmaceutical sector to OctoPlus. He graduated from Erasmus University Medical School in the Netherlands and he pursued the clinical part of his training at Harvard Medical School. He obtained his MBA from Stanford and started his business career in clinical research at Organon Teknika in Belgium. He worked for four years as a strategic consultant to life sciences companies at McKinsey & Company, and from 1994 onwards held business development and general management positions of increasing responsibility in the USA at Merck, Johnson & Johnson and Mölnlycke Health Care. He became CEO of Novadel Pharmaceuticals, Inc. in 2005. Subsequently, Dr. Egberts has served as Senior Advisor in healthcare investments to private equity firm 3i Group and has also gained experience in non-executive positions.
Susan Swarte - Chief Financial Officer
Susan Swarte has over 16 years of experience in financial and strategic management. She worked at Unilever and Numico (now Danone), two large, international and publicly listed companies, where she was responsible for financial, logistic and reporting aspects. At Numico she professionalised the finance function in China and most recently she was responsible for all financial aspects of the export business of Danone Baby Nutrition as Finance Director, Global Export.
Gerben Moolhuizen – Chief Business Officer
Mr. Moolhuizen received a Master’s Degree in Medical Biology from Utrecht University in 1991, studied at Tohoku University, Sendai, Japan and received an MBA from the Erasmus University of Rotterdam School of Management. He then joined Pharming Group N.V. where he held positions in Business Development, eventually becoming Director, Business Development. In 1999, Mr. Moolhuizen joined ASD B.V. (currently Primagen B.V.) as Vice-President, Business Development. He joined OctoPlus in 2001, as Senior Manager, Business Development. He became Chief Business Officer in January 2006.